DBVT · DBV Technologies S.A.
$13.48
-0.02 (-0.15%)
At close · Jul 29
Market Cap
$4.00B
Shares
296.06M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$5.64M
+35.8%
FY2025
Net Income
-$146.95M
-29%
FY2025
Operating Margin
-2609.23%
+199.5pp
FY2025
Diluted EPS
-$1.05
+10.3%
FY2025
Operating Cash Flow
-$121.18M
-16%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| $4.94M | $5.64M | $4.15M | $15.73M | $4.84M | $5.71M | $11.28M | $14.71M | |
| $126.08M | $116.68M | $89.34M | $60.22M | $75.54M | $70.34M | $101.61M | $115.1M | |
| $12.82M | $3.22M | $2.66M | $2.44M | $1.61M | $4.39M | $9.88M | $21.56M | |
| $43.79M | $32.79M | $28.74M | $29.5M | $24.32M | $30.52M | $35.08M | $49.07M | |
| — | $2.99M | $2.72M | $3.57M | — | — | — | — | |
| — | — | — | — | — | $0 | $23.55M | — | |
| $182.79M | $152.69M | $120.74M | $92.16M | $101.48M | $104.32M | $170.12M | $185.73M | |
| -$177.86M | -$147.06M | -$116.59M | -$76.43M | -$96.63M | -$98.61M | -$158.84M | -$171.02M | |
| — | -2609.23% | -2808.7% | -485.96% | -1994.86% | -1727.65% | -1408.67% | -1162.79% | |
| — | -$144.07M | -$113.87M | -$72.87M | — | — | — | — | |
| -$175.16M | -$146.46M | -$113.86M | -$72.72M | -$96.2M | -$98.19M | -$159.57M | -$171.4M | |
| $791K | $491K | $55K | $7000 | $70K | -$381K | -$10K | $610K | |
| -$175.95M | -$146.95M | -$113.92M | -$72.71M | $96.27M | -$97.81M | -$159.56M | -$172.01M | |
| — | -2607.29% | -2744.35% | -462.3% | 1987.49% | -1713.54% | -1415% | -1169.51% | |
| — | -$146.95M | -$113.92M | -$72.73M | -$96.27M | -$97.81M | -$159.56M | -$172.01M | |
| -$182.29M | -$140.19M | -$117.98M | -$67.05M | -$104.44M | -$110.07M | -$136.08M | -$172.38M | |
| USD/shares | — | -$1.05 | -$1.17 | -$0.76 | -$2.48 | -$3.56 | — | — |
| USD/shares | — | -$1.05 | -$1.17 | -$0.76 | -$2.48 | -$3.56 | — | — |
| shares | — | 139.57M | 97M | 95.12M | 38.69M | 27.46M | 27.05M | 18.5M |
| shares | — | 139.57M | 97M | 95.12M | 38.69M | 27.46M | 27.05M | 18.5M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 8.73×
EV/EBIT
—
Peer median 24.96×
P/E (TTM)
—
Peer median 19.19×
Peer medians compare against the 202 similar-size Biotechnology companies (of 522 listed).